 180 Life Sciences Corp NASDAQ: ATNF shares are trading higher following insider buying from Marc Feldmann, a director on the companys board, and Jonathan Rothbard, the companys chief scientific officer. 180 Life Sciences is a clinical-stage biotechnology company. 